TriangleNCT02860286 · OUTCOME
Progression-free Survival (PFS)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- Weeks
- Interval / dispersion
- Inter-Quartile Range
- Time frame
- The patients were assessed for PFS for up to 24 weeks
What was measured
Progression-Free Survival is defined as the interval of time between the date of the first dose of study drug and the earliest date of disease progression or death due to any cause. PFS was analyzed and listed for the ITT population. PFS was calculated using the Kaplan-Meier method.
Groups in this outcome
Part 1
Part 1 - Subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status Part 2: Subjects with relapsed or refractory BAP1-deficient malignant mesothelioma
Part 2
Subjects with relapsed or refractory BAP1-deficient malignant mesothelioma
| Group | Source count |
|---|---|
| Part 1 | 13 |
| Part 2 | 61 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Part 1 | 12 | Not reported | 5.4 | 34.1 | Not reported |
| Part 2 | 18 | Not reported | 1.6 | 114.3 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 5.4
- upper Limit
- 34.1
- value
- 12
- group Id
- OG001
- lower Limit
- 1.6
- upper Limit
- 114.3
- value
- 18
- denoms
- counts
- group Id
- OG000
- value
- 13
- group Id
- OG001
- value
- 61
- units
- Participants
- description
- Progression-Free Survival is defined as the interval of time between the date of the first dose of study drug and the earliest date of disease progression or death due to any cause. PFS was analyzed and listed for the ITT population. PFS was calculated using the Kaplan-Meier method.
- dispersion Type
- Inter-Quartile Range
- groups
- description
- Part 1 - Subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status Part 2: Subjects with relapsed or refractory BAP1-deficient malignant mesothelioma
- id
- OG000
- title
- Part 1
- description
- Subjects with relapsed or refractory BAP1-deficient malignant mesothelioma
- id
- OG001
- title
- Part 2
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- The patients were assessed for PFS for up to 24 weeks
- title
- Progression-free Survival (PFS)
- type
- SECONDARY
- unit Of Measure
- Weeks
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice